Thackray Helen M. (CIK 0001589725)

Latest company ownership

BCRX - BIOCRYST PHARMACEUTICALS INC
Role: Chief R&D Officer
Shares held
377,318
Last filed at
Apr 2, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q2 2025Q4
CBIO - CRESCENT BIOPHARMA, INC.
Role: SVP Clinical Development, CMO
Shares held
69,000
Last filed at
Jan 22, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 31, 2025 Apr 2, 2025 BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Sell 42.5 -7,525 -1.96% ✗ $56.4K
Dec 19, 2024 Dec 23, 2024 BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Sell 91.3 +119,854 45.23% ✗ $45K
Dec 14, 2024 Dec 17, 2024 BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Sell 42.5 -7,150 -2.63% ✗ $53.8K
May 14, 2024 May 15, 2024 BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Buy 95.0 +30,000 12.39% ✗ $175.8K
Mar 31, 2024 Apr 2, 2024 BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Sell 46.3 -7,525 -3.01% ✗ $38.2K
Dec 19, 2023 Dec 20, 2023 BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Sell 46.3 -5,580 -2.19% ✗ $33.8K
Dec 14, 2023 Dec 18, 2023 BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Sell 91.3 +47,969 23.14% ✗ $19.5K
Apr 3, 2023 Apr 5, 2023 BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Sell 37.5 -7,000 -3.27% ✓ $58K
Dec 15, 2022 Dec 19, 2022 BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Sell 45.0 -3,125 -2.29% ✓ $34K
Apr 1, 2022 Apr 4, 2022 BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Sell 32.5 -7,600 -5.28% ✓ $123.1K
Dec 8, 2017 Dec 12, 2017 CRESCENT BIOPHARMA, INC. SVP Clinical Development, CMO Sell 26.3 -2,000 -1.33% ✗ $30K
Sep 18, 2017 Sep 18, 2017 CRESCENT BIOPHARMA, INC. SVP Clinical Development, CMO Sell 26.3 -2,000 -1.31% ✗ $26K
May 25, 2017 May 30, 2017 CRESCENT BIOPHARMA, INC. SVP Clinical Development, CMO Sell 26.3 -2,000 -1.29% ✗ $31.1K
May 19, 2017 May 22, 2017 CRESCENT BIOPHARMA, INC. SVP Clinical Development, CMO Sell 48.8 -2,000 -1.28% ✓ $24.3K
Oct 3, 2016 Oct 4, 2016 CRESCENT BIOPHARMA, INC. VP Clinical Development, CMO Sell 45.0 -4,000 -2.49% ✓ $28K
Jul 20, 2016 Jul 21, 2016 CRESCENT BIOPHARMA, INC. VP Clinical Development, CMO Sell 48.8 -2,000 -1.23% ✓ $16K
Jul 1, 2016 Jul 6, 2016 CRESCENT BIOPHARMA, INC. VP Clinical Development, CMO Sell 25.0 -22,000 -11.92% ✓ $154K